Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer. [electronic resource]
Producer: 20170517Description: 887-92 p. digitalISSN:- 1090-2104
- Administration, Intravesical
- Antineoplastic Agents -- isolation & purification
- Apoptosis -- drug effects
- Cell Line, Tumor
- Claudin-4 -- genetics
- Clostridium perfringens -- chemistry
- Dasatinib -- pharmacology
- Drug Evaluation, Preclinical
- Enterotoxins -- biosynthesis
- Epithelial Cells -- drug effects
- Gene Expression Regulation, Neoplastic
- Humans
- Mitomycin -- pharmacology
- Models, Biological
- Molecular Targeted Therapy
- Protein Binding
- Receptor, EphA2 -- genetics
- Recombinant Proteins -- biosynthesis
- Spheroids, Cellular -- drug effects
- Urinary Bladder Neoplasms -- drug therapy
- Urothelium -- drug effects
- src-Family Kinases -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.